drugset / Trial / NCT05699993
A Study of IBI351 in Healthy Subjects
Non-randomizedParallel-groupOpen-labelOther
Summary
This is an open-label, two-cycle clinical study to evaluate the drug interaction between itraconazole or dextromethorphan and IBI351 in healthy subjects. A total of two cohorts of 12 healthy male subjects were planned to be enrolled in each cohort.
Timeline
- Start
- 2023-03-10
- Primary completion
- 2023-10-16
- Completion
- 2023-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextromethorphan | Unknown | — | Oral |
| Subject | IBI351 | Small molecule | — | Oral |
| Subject | Itraconazole | Small molecule | — | Oral |
Indications
No indication recorded.